Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Pharmacology

Background:

• Hypertension is common and challenging to manage in the elderly.
• Monotherapy is often insufficient for blood pressure control in older adults.
• Single-pill combination therapy offers a promising approach for managing hypertension in this population.

Purpose of the Study:

• To review the literature on hypertension management in the elderly.
• To focus on the efficacy of single-pill combination therapy with amlodipine and valsartan.
• To evaluate the benefits of this combination in older hypertensive patients.

Main Methods:

• Review of controlled clinical trials.
• Analysis of efficacy data for amlodipine/valsartan combination therapy versus amlodipine monotherapy.
• Assessment of safety and tolerability, including peripheral edema incidence.

Main Results:

• Amlodipine/valsartan combination therapy demonstrated superior blood pressure reduction compared to amlodipine monotherapy in older patients with stage 1 or 2 hypertension.
• This efficacy was consistent across different demographic groups, including older black hypertensive patients.
• The combination therapy showed a reduced incidence of peripheral edema and is metabolically neutral, making it suitable for patients with diabetes or metabolic syndrome.

Conclusions:

• Single-pill combination therapy with amlodipine/valsartan is highly effective for managing hypertension in the elderly.
• This combination improves blood pressure control and patient adherence due to better tolerability.
• It is a valuable therapeutic option for high-risk elderly individuals, including those with comorbidities like diabetes or metabolic syndrome.